Desiree L. Long, PA

Desiree Long practices at Cayuga Medical Associates in Ithaca, New York.

Desiree Long's NPI, 1508167644, was assigned on November 5, 2010. Desiree Long holds New York license 014364.

Desiree Long's primary practice is Cayuga Medical Associates, at 905 Hanshaw Rd, Ithaca, NY 14850 in Tompkins County. The practice phone is (607) 274-4011.

Desiree Long's primary practice is Cayuga Medical Associates in Ithaca, New York. Desiree Long is also affiliated with Cayuga Medical Center. The medical group on file is Cayuga Medical Associates. Dmand AI also links Desiree Long to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Desiree Long practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Desiree Long's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Desiree Long is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Desiree Long is licensed in New York.

Dmand AI lists fibromyalgia and chronic pain, lower back pain, neck pain and spine problems and thoracic spine disorders among the conditions Desiree Long treats.

CMS data shows 391 Medicare services from Desiree Long across 2 procedure codes in 2024, all of them office visits, for 211 Medicare patients. Medicare paid $22,462 for them. Every service was in an office.

CMS counts 211 Medicare patients who saw Desiree Long in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have arthritis, and 69% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Desiree Long's median patient age at 60, with 63% women.

In 2024, Desiree Long wrote 60 Medicare Part D claims for 44 patients. 100% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $136 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Desiree Long for performance year 2024, reported through an alternative payment model (APM). Desiree Long accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Desiree Long as offering telehealth.

CMS Open Payments shows 26 general payments to Desiree Long from 13 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $146.